Factors associated with infection in groups with clinical risk conditions for complications from COVID-19

Authors

  • Fernando José Guedes da Silva Júnior Universidade Federal do Piauí - UFPI, Centro de Ciências da Saúde, Enfermagem. Teresina, PI - Brasil.
  • Jaqueline Carvalho e Silva Sales Universidade Federal do Piauí - UFPI, Centro de Ciências da Saúde, Enfermagem. Teresina, PI - Brasil. https://orcid.org/0009-0009-8607-7650
  • Chrystiany Plácido de Brito Vieira Universidade Federal do Piauí - UFPI, Centro de Ciências da Saúde, Enfermagem. Teresina, PI - Brasil. https://orcid.org/0000-0002-3429-3329
  • Ana Paula Cardoso Costa Universidade Federal do Piauí - UFPI, Centro de Ciências da Saúde, Enfermagem. Teresina, PI - Brasil. https://orcid.org/0000-0002-1550-3685
  • Luana Ruth Braga Campos Universidade Federal do Piauí - UFPI, Centro de Ciências da Saúde, Enfermagem. Teresina, PI - Brasil. https://orcid.org/0000-0001-6993-8644
  • Priscilla Ingrid Gomes Miranda Universidade Federal do Piauí - UFPI, Centro de Ciências da Saúde, Enfermagem. Teresina, PI - Brasil. https://orcid.org/0000-0001-8948-7158
  • Andreia Alves de Sena Silva Fundação Municipal de Saúde - FMS, Atenção Primária. Teresina, PI - Brasil
  • Karoline Alencar Rodrigues Fundação Municipal de Saúde - FMS, Atenção Primária. Teresina, PI - Brasil. https://orcid.org/0000-0002-7150-5175

DOI:

https://doi.org/10.5935/1415-2762-20210054

Keywords:

Coronavirus Infections, Risk Factors, Pandemics

Abstract

Objective: to analyze the risk factors associated with COVID-19 infection in groups with clinical risk conditions for the development of complications from the disease. Method: this is a retrospective census study with data from rapid tests for COVID-19 carried out in Fast Track Basic Health Units in Teresina-Piauí, between April 26 and July 15, 2020. Information from 16,449 individuals was analyzed through a standard form and, in case of a positive test, also notification forms for influenza syndrome suspected of having a disease caused by the coronavirus 2019 we analyzed. For statistical analysis, the Statistical Package for Social Science, version 22.0, was used. The study was approved by the Research Ethics Committee of the Universidade Federal do Piauí. Results: 22.30% of those
investigated had some risk factor for the development of complications by COVID-19. There was a statistically significant association between the test result for COVID-19 and cardiac risk factor (p=0.020), diabetes mellitus (p=0.000), arterial hypertension (p=0.000), smoking (p=0.013), and dyslipidemia (p=0.028). As for the approach adopted because of the positive results for COVID-19,
an association was detected with the variables risk factor (p=0.000), cardiac risk factor (p=0.000), diabetes mellitus (p=0.000), and obesity (p =0.003). Possessing a risk factor, heart problem, diabetes, or obesity was associated with the severity of COVID-19, represented by the conduct of referral to the emergency department. Conclusion: The study provides a comprehensive reference of information
in response to the COVID-19 pandemic in the capital of Piauí. It is believed that it will support the development of control actions, especially among those at risk for complications from the disease.

Downloads

Download data is not yet available.

References

1- Ministério da Saúde (BR). Secretaria de Vigilância em Saúde.

Guia de Vigilância Epidemiológica: Emergência de Saúde Pública

de Importância Nacional pela Doença pelo Coronavírus 2019.

Brasília: Ministério da Saúde; 2020[citado em 2020 dez. 12].

Disponível em: https://portalarquivos.saude.gov.br/images/af_

gvs_coronavirus_6ago20_ajustes-finais-2.pdf

2- World Health Organization (WHO). Responding to community spread

of COVID19: interim guidance. Geneve: WHO; 2020[citado em 2020

abr. 06]. Disponível em: https://www.who.int/publicationsdetail/

responding-to-community-spread-of-COVID-19

3- Ministério da Saúde (BR). Secretaria de Atenção Primária à Saúde.

Departamento de Ações Programáticas e Estratégicas. Nota Informativa

nº 13/2020 - SE/GAB/SE/MS. Manual de Recomendações para a

Assistência à Gestante e Puérpera frente à Pandemia de Covid-19.

Brasília: Ministério da Saúde; 2020[citado em 2021 fev. 12]. Disponível

em: http://antigo.saude.gov.br/images/pdf/2020/September/02/

Manual-de-Recomenda----es-para-Gestante.pdf

4- Secretaria de Estado da Saúde do Piauí (BR). Painel Epidemiológico Covid-

19 - 2021[citado em 2021 mar. 30]. Disponível em: https://datastudio.

google.com/reporting/a6dc07e9-4161-4b5a-9f2a-6f9be486e8f9/

page/2itOB

5- Ministério da Saúde (BR). Diretrizes para diagnóstico e tratamento

da COVID-19. Brasília: Ministério da Saúde; 2020[citado em

2020 abr. 14]. Disponível em: http://portalarquivos.saude.gov.br/

images/pdf/2020/April/10/Diretrizes-covid-V2-9.4.pdf

6- Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological

and clinical characteristics of 99 cases of 2019 novel coronavirus

pneumonia in Wuhan, China: a descriptive study. Lancet. 2020[citado

em 2020 dez. 12];395(10223):507-13. Disponível em: https://doi.

org/10.1016/S0140-6736(20)30211-7

7- Magalhães JJF, Mendes RPG, Silva CTA, Silva SJR, Guarines KM,

Pena L, et al. Epidemiological and clinical characteristics of the

first 557 successive patients with COVID-19 in Pernambuco state,

Northeast Brazil. Travel Med Infect Dis. 2020[citado em 2020

dez. 19];38:101884. Disponível em: https://doi.org/10.1016/j.

tmaid.2020.101884

8- Instituto Brasileiro de Geografia e Estatística (IBGE). Pesquisa

Nacional de Saúde: 2019 - atenção primária à saúde e informações

antropométricas. Brasil. Rio de Janeiro: IBGE; 2020[citado em

2021 mar. 30]. Disponível em: https://biblioteca.ibge.gov.br/

visualizacao/livros/liv101758.pdf

9- Silva AWC, Cunha AA, Alves GC, Corona RA, Dias CAGM, Nassiri

R, et al. Caracterização clínica e epidemiologia de 1560 casos

de COVID-19 em Macapá/AP, extremo norte do Brasil. Res Soc

Develop 2020[citado em 2020 dez. 20]; 9(8):e150985499.

Disponível em: http://dx.doi.org/10.33448/rsd-v9i8.5499

10- Rosa MFP, Silva WNT, Carvalho WRG, Oliveira SV. Epidemiologia

da COVID-19 em Uberlândia (MG): análise preliminar do impacto

do grau de abertura comercial. J. Health NPEPS. 2020[citado

em 2020 dez. 20];5(2):20-41. Disponível em: http://dx.doi.

org/10.30681/252610104844

11- Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics

of Coronavirus Disease 2019 in China. N Engl J Med. 2020[citado

em 2020 dez. 22];382(18):1708-20. Disponível em: https://doi.

org/10.1056/NEJMoa2002032

12- Adhikari SP, Meng S, Wu Y, Mao Y, Ye R, Wang Q, et al. Epidemiology,

causes, clinical manifestation and diagnosis, prevention and control

of coronavirus disease (COVID-19) during the early outbreak

period: a scoping review. Infect Dis Poverty. 2020[citado em

2020 dez. 22];9(1):29. Disponível em: https://doi.org/10.1186/

s40249-020-00646-x

13- Zaki N, Alashwal H, Ibrahim S. Association of hypertension,

diabetes, stroke, cancer, kidney disease, and high-cholesterol with

COVID-19 disease severity and fatality: a systematic review. Diab

Metab Syndr. 2020[citado em 2020 dez. 29];14(5):1133-42.

Disponível em: https://doi.org/10.1016/j.dsx.2020.07.005

14- Fang L, Karakiulakis G, Roth M. Are patients with hypertension and

diabetes mellitus at increased risk for COVID-19 infection? Lancet

Respir Med. 2020[citado em 2020 dez. 23];8(4):e21. Disponível

em: https://doi.org/10.1016/S2213-2600(20)30116-8

15- Zyl-Smit RN, Richards G, Leone FT. Tobacco smoking and

COVID-19 infection. Lancet Respir Med. 2020[citado em 2020

dez. 28];8(7):664-5. Disponível em: https://doi.org/10.1016/

S2213-2600(20)30239-3

16- Hariyanto TI, Kurniawan A. Dyslipidemia is associated with severe

coronavirus disease 2019 (COVID-19) infection. Diab Metab Syndr.

2020[citado em 2020 dez. 29];14(5):1463-5. Disponível em:

https://doi.org/10.1016/j.dsx.2020.07.054

17- Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate

immunity. Nat Rev Immunol. 2015[citado em 2020 dez. 30];15(2):104-

16. Disponível em: https://doi.org/10.1038/nri3793

18- Dietz W, Santos-Burgoa C. Obesity and its Implications for COVID-

19- Mortality. Obesity (Silver Spring). 2020[citado em 2021 jan.

06];28(6):1005. Disponível em: https://doi.org/10.1002/oby.22818

19. Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and

diabetes mellitus. Am J Physiol Endocrinol Metab. 2020[citado

em 2021 jan. 07];318(5):E736-41. Disponível em: https://doi.

org/10.1152/ajpendo.00124.2020

20- Momtazmanesh S, Shobeiri P, Hanaei S, Mahmoud-Elsayed H,

Dalvi B, Rad EM. Cardiovascular disease in COVID-19: a systematic

review and meta-analysis of 10,898 patients and proposal of

a triage risk stratification tool. Egypt Heart J. 2020[citado em

2021 jan. 10];72:41. Disponível em: https://doi.org/10.1186/

s43044-020-00075-z

21- Robinson E, Boyland E, Chisholm A, Harrold J, Maloney NG,

Marty L, et al. Obesity, eating behavior and physical activity during

COVID-19 lockdown: a study of UK adults. Appetite. 2021[citado

em 2021 jan. 12];156:104853. Disponível em: https://doi.

org/10.1016/j.appet.2020.104853

22- Albashir AAD. The potential impacts of obesity on COVID-19.

Clin Med (Lond). 2020[citado em 2021 jan. 12];20(4):e109-13.

Disponível em: https://doi.org/10.7861/clinmed.2020-0239

23- Espinosa OA, Zanetti AS, Antunes EF, Longhi FG, Matos TA, Battaglini

PF. Prevalence of comorbidities in patients and mortality cases affected

by SARS-CoV2: a systematic review and meta-analysis. Rev Inst Med

Trop Sao Paulo. 2020[citado em 2021 jul. 17];62:e43. Disponível em:

https://doi.org/10.1590/S1678-9946202062043

24- Paules CI, Marston HD, Fauci AS. Coronavirus Infections-more than just

the common cold. JAMA. 2020[citado em 2021 fev. 02];323(8):707-8.

Disponível em: https://doi.org/10.1001/jama.2020.0757

25- Borges GM, Crespo CD. Aspectos demográficos e socioeconômicos

dos adultos brasileiros e a COVID-19: uma análise dos grupos de

risco a partir da Pesquisa Nacional de Saúde, 2013. Cad Saúde

Pública. 2020[citado em 2021 fev. 08];36(10):e00141020.

Disponível em: https://doi.org/10.1590/0102-311x00141020

26- Antunes BBP, Peres IT, Baião FA, Ranzani OT, Bastos LSL, Silva

AAB, et al. Progressão dos casos confirmados de COVID-19 após

implantação de medidas de controle. Rev Bras Ter Intensiva.

2020[citado em 2021 fev. 08];32(2):213-23. Disponível em:

https://doi.org/10.5935/0103-507x.20200028

Published

2021-08-10

Issue

Section

Research

How to Cite

1.
Factors associated with infection in groups with clinical risk conditions for complications from COVID-19. REME Rev Min Enferm. [Internet]. 2021 Aug. 10 [cited 2026 Apr. 4];25. Available from: https://periodicos.ufmg.br/index.php/reme/article/view/54983

Most read articles by the same author(s)